CN103096882A - 含有多奈哌齐的经皮吸收制剂 - Google Patents
含有多奈哌齐的经皮吸收制剂 Download PDFInfo
- Publication number
- CN103096882A CN103096882A CN2011800325811A CN201180032581A CN103096882A CN 103096882 A CN103096882 A CN 103096882A CN 2011800325811 A CN2011800325811 A CN 2011800325811A CN 201180032581 A CN201180032581 A CN 201180032581A CN 103096882 A CN103096882 A CN 103096882A
- Authority
- CN
- China
- Prior art keywords
- transdermal formulation
- weight
- donepezil
- formulation according
- methacrylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
色谱柱 | C-18(Gemini,10cm,5μm) |
流动相 | 乙腈/磷酸盐缓冲液(pH2.7)=70/30 |
流速 | 1ml/min |
分析波长 | 315nm |
温度 | 30℃ |
Claims (11)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2010-0062433 | 2010-06-30 | ||
KR20100062433A KR101192969B1 (ko) | 2010-06-30 | 2010-06-30 | 도네페질을 함유하는 경피흡수제제 |
PCT/KR2011/003052 WO2012002640A2 (ko) | 2010-06-30 | 2011-04-27 | 도네페질을 함유하는 경피흡수제제 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103096882A true CN103096882A (zh) | 2013-05-08 |
CN103096882B CN103096882B (zh) | 2014-06-11 |
Family
ID=45402504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180032581.1A Expired - Fee Related CN103096882B (zh) | 2010-06-30 | 2011-04-27 | 含有多奈哌齐的经皮吸收制剂 |
Country Status (12)
Country | Link |
---|---|
US (2) | US9155711B2 (zh) |
EP (1) | EP2589379B1 (zh) |
JP (1) | JP5680197B2 (zh) |
KR (1) | KR101192969B1 (zh) |
CN (1) | CN103096882B (zh) |
AU (1) | AU2011272174A1 (zh) |
CA (1) | CA2804148C (zh) |
ES (1) | ES2785992T3 (zh) |
MY (1) | MY163809A (zh) |
NZ (1) | NZ605352A (zh) |
SG (1) | SG186777A1 (zh) |
WO (1) | WO2012002640A2 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112823793A (zh) * | 2019-11-20 | 2021-05-21 | 成都康弘药业集团股份有限公司 | 一种含有多奈哌齐的透皮贴剂及其制备方法 |
CN113825499A (zh) * | 2019-05-15 | 2021-12-21 | 株式会社大熊制药 | 含有高剂量的多奈哌齐或其盐的经皮吸收制剂 |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI433904B (zh) * | 2011-01-12 | 2014-04-11 | Taiwan Biotech Co Ltd | 多奈哌齊經皮貼片 |
KR101317158B1 (ko) | 2011-02-18 | 2013-10-15 | 조선대학교산학협력단 | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 |
KR101239150B1 (ko) * | 2012-02-28 | 2013-03-06 | 에스케이케미칼주식회사 | 도네페질-함유 경피흡수제제 및 그의 제조방법 |
WO2014159748A1 (en) * | 2013-03-13 | 2014-10-02 | Nal Pharmaceuticals, Ltd. | Transdermal drug delivery system containing donepezil |
WO2014159778A1 (en) * | 2013-03-13 | 2014-10-02 | Nal Pharmaceuticals, Ltd. | Transdermal drug delivery system containing fentanyl |
CN105263488A (zh) * | 2013-03-15 | 2016-01-20 | 纳尔制药有限公司 | 含卡巴拉汀的经皮给药系统 |
WO2015127280A1 (en) | 2014-02-20 | 2015-08-27 | Nal Pharmaceuticals, Ltd. | Transdermal drug delivery system containing donepezil |
RU2713207C2 (ru) | 2014-12-18 | 2020-02-04 | Айкьюре Фармасьютикал Инк. | Трансдермальная композиция, содержащая донепезил в качестве активного ингредиента |
AU2017301928B2 (en) * | 2016-07-27 | 2023-04-06 | Corium, LLC. | Donepezil transdermal delivery system |
EP3700511A1 (en) | 2017-10-17 | 2020-09-02 | Lubrizol Advanced Materials, Inc. | Composition and device for delivery of active agents to skin surfaces |
WO2020047205A1 (en) * | 2018-08-31 | 2020-03-05 | Arctic Therapeutics, Llc | Novel topical formulation for intradermal application and uses thereof |
KR102227100B1 (ko) * | 2020-08-14 | 2021-03-12 | 주식회사 종근당 | 도네페질 에테르 팔미테이트 또는 이의 약제학적으로 허용가능한 염 |
CN117500923A (zh) | 2021-04-07 | 2024-02-02 | 巴特尔纪念研究院 | 用于鉴定和使用非病毒载体的快速设计、构建、测试和学习技术 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050037405A (ko) * | 2001-10-17 | 2005-04-21 | 히사미쯔 제약 주식회사 | 경피 흡수형 제제 |
US20080138388A1 (en) * | 2005-02-04 | 2008-06-12 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal Absorption Patch |
KR20090009951A (ko) * | 2006-05-08 | 2009-01-23 | 데이고꾸세이약꾸가부시끼가이샤 | 항치매제를 포함하는 경피 흡수 제제 |
US20090098191A1 (en) * | 2007-10-16 | 2009-04-16 | Anderson Christopher G | Use of bases to stabilize transdermal formulations |
KR20090085090A (ko) * | 2006-12-01 | 2009-08-06 | 닛토덴코 가부시키가이샤 | 경피 흡수 제제 |
US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3987655B2 (ja) | 1998-03-03 | 2007-10-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬を含有した経皮適用製剤又は坐剤 |
BR0207955A (pt) * | 2001-03-07 | 2004-02-25 | Hisamitsu Pharmaceutical Co | Agente de emplastro |
TW593614B (en) | 2001-03-16 | 2004-06-21 | Nat Starch Chem Invest | Rubber-acrylic adhesive formulation |
GB2402394B (en) * | 2002-03-25 | 2005-12-07 | Nat Starch Chem Invest | Rubber-acrylic adhesive formulation |
JP5097359B2 (ja) | 2006-05-09 | 2012-12-12 | 久光製薬株式会社 | ドネペジル経皮吸収型製剤 |
KR101432698B1 (ko) * | 2006-06-06 | 2014-08-22 | 다우 코닝 코포레이션 | 실리콘 아크릴레이트 하이브리드 조성물 |
BRPI0719307A2 (pt) | 2006-12-01 | 2014-02-04 | Nitto Denko Corp | Método para a supressão da descoloração ao longo do tempo da preparação adesiva contendo donepezil. |
KR101454362B1 (ko) | 2008-03-24 | 2014-10-23 | 아이큐어 주식회사 | 도네페질을 유효성분으로 함유하는 치매 치료용경피흡수제제 |
JP2012504163A (ja) | 2008-09-30 | 2012-02-16 | テイコク ファーマ ユーエスエー インコーポレーテッド | 経皮持続送達ドネペジル組成物および該組成物を使用する方法 |
WO2011034323A2 (en) * | 2009-09-16 | 2011-03-24 | Samyang Corporation | Transdermal delivery system, method for manufacturing the same, and transdermal delivery method using the system |
-
2009
- 2009-07-15 NZ NZ60535209A patent/NZ605352A/xx not_active IP Right Cessation
-
2010
- 2010-06-30 KR KR20100062433A patent/KR101192969B1/ko active IP Right Grant
-
2011
- 2011-04-27 ES ES11801047T patent/ES2785992T3/es active Active
- 2011-04-27 MY MYPI2012005653A patent/MY163809A/en unknown
- 2011-04-27 CN CN201180032581.1A patent/CN103096882B/zh not_active Expired - Fee Related
- 2011-04-27 AU AU2011272174A patent/AU2011272174A1/en not_active Abandoned
- 2011-04-27 JP JP2013518221A patent/JP5680197B2/ja not_active Expired - Fee Related
- 2011-04-27 SG SG2012093944A patent/SG186777A1/en unknown
- 2011-04-27 CA CA2804148A patent/CA2804148C/en not_active Expired - Fee Related
- 2011-04-27 EP EP11801047.9A patent/EP2589379B1/en active Active
- 2011-04-27 WO PCT/KR2011/003052 patent/WO2012002640A2/ko active Application Filing
- 2011-04-27 US US13/806,565 patent/US9155711B2/en active Active
-
2015
- 2015-08-12 US US14/825,071 patent/US9693970B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050037405A (ko) * | 2001-10-17 | 2005-04-21 | 히사미쯔 제약 주식회사 | 경피 흡수형 제제 |
US20080138388A1 (en) * | 2005-02-04 | 2008-06-12 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal Absorption Patch |
KR20090009951A (ko) * | 2006-05-08 | 2009-01-23 | 데이고꾸세이약꾸가부시끼가이샤 | 항치매제를 포함하는 경피 흡수 제제 |
KR20090085090A (ko) * | 2006-12-01 | 2009-08-06 | 닛토덴코 가부시키가이샤 | 경피 흡수 제제 |
US20090098191A1 (en) * | 2007-10-16 | 2009-04-16 | Anderson Christopher G | Use of bases to stabilize transdermal formulations |
US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113825499A (zh) * | 2019-05-15 | 2021-12-21 | 株式会社大熊制药 | 含有高剂量的多奈哌齐或其盐的经皮吸收制剂 |
CN113825499B (zh) * | 2019-05-15 | 2024-03-08 | 株式会社大熊制药 | 含有高剂量的多奈哌齐或其盐的经皮吸收制剂 |
CN112823793A (zh) * | 2019-11-20 | 2021-05-21 | 成都康弘药业集团股份有限公司 | 一种含有多奈哌齐的透皮贴剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
AU2011272174A1 (en) | 2013-01-24 |
US20150352058A1 (en) | 2015-12-10 |
EP2589379A4 (en) | 2013-12-18 |
KR20120001844A (ko) | 2012-01-05 |
SG186777A1 (en) | 2013-02-28 |
NZ605352A (en) | 2013-10-25 |
CA2804148C (en) | 2018-03-20 |
CN103096882B (zh) | 2014-06-11 |
JP5680197B2 (ja) | 2015-03-04 |
ES2785992T3 (es) | 2020-10-08 |
JP2013529680A (ja) | 2013-07-22 |
EP2589379B1 (en) | 2020-02-26 |
WO2012002640A3 (ko) | 2012-04-12 |
US9693970B2 (en) | 2017-07-04 |
WO2012002640A2 (ko) | 2012-01-05 |
CA2804148A1 (en) | 2012-01-05 |
EP2589379A2 (en) | 2013-05-08 |
US9155711B2 (en) | 2015-10-13 |
KR101192969B1 (ko) | 2012-10-19 |
MY163809A (en) | 2017-10-31 |
US20130095168A1 (en) | 2013-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103096882B (zh) | 含有多奈哌齐的经皮吸收制剂 | |
US20140370076A1 (en) | Transdermal drug delivery system containing donepezil | |
US5866157A (en) | Matrix patch formulation | |
KR101734602B1 (ko) | 도네페질 함유 경피 흡수형 제제 | |
EP0561983B1 (en) | Systems for administering drugs transdermally using sorbitan esters as skin permeation enhancers | |
JP6391664B2 (ja) | リバスチグミンを含む、経皮薬物送達システム | |
EP2654739B1 (en) | Percutaneous absorption preparation containing rivastigmine | |
JP4694967B2 (ja) | 貼付剤 | |
WO2006080199A1 (ja) | 貼付剤 | |
AU2577500A (en) | A transdermal composition of an antivomiting agent and a preparation containing the same | |
EP1589973B2 (en) | Formulation and methods for the treatment of thrombocythemia | |
KR100929560B1 (ko) | 그라니세트론을 함유한 매트릭스 형태의 경피 흡수제 | |
JP5883459B2 (ja) | ガランタミンまたはその塩を含む経皮送達システム | |
WO2014159748A1 (en) | Transdermal drug delivery system containing donepezil | |
Myoung et al. | Effects of vehicles and pressure sensitive adhesives on the penetration of isosorbide dinitrate across the hairless mouse skin | |
JP2023542937A (ja) | 最小用量のオランザピンによる嘔吐及び悪心の治療 | |
US20140370077A1 (en) | Transdermal drug delivery system containing fentanyl | |
CN113874011B (zh) | 外用制剂 | |
KR101566817B1 (ko) | 케토티펜 또는 그 염을 함유하는 경피흡수제제 | |
WO2014159778A1 (en) | Transdermal drug delivery system containing fentanyl |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160620 Address after: Hongkong Tongluowan China Gloucester Road No. 311 royal building room 2109 Patentee after: Royal Pharmaceutical Group Address before: Hongkong, China Patentee before: Nal Pharmaceuticals Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: Hongkong Tongluowan China Gloucester Road No. 311 royal building room 2109 Patentee after: Aneng Tai Pharmaceutical Co. Ltd. Address before: Hongkong Tongluowan China Gloucester Road No. 311 royal building room 2109 Patentee before: Royal Pharmaceutical Group |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140611 Termination date: 20210427 |
|
CF01 | Termination of patent right due to non-payment of annual fee |